Promisia Healthcare Limited logo

Director resignation and re-appointment

Director Appointment4 December 2018PHLHealthcare

NZX Announcement

3 December 2018


Resignation and re-appointment of Mr Tom Brankin as a director of the company.


The Directors of Promisia Integrative Limited (NZX:PIL) advise that due to an administrative oversight

director Thomas Brankin was not nominated for re-election at the annual meeting of shareholders

held on 31 May 2018 as required by the NZX Listing Rules. Listing Rule 3.3.11 requires that one third

of directors retire by rotation each year and that their reappointment should be placed before

shareholders for consideration at the annual meeting of shareholders.

This administrative oversight and inadvertent breach of the Listing Rules does not have any impact

on the decisions of the directors since 31 May 2018 or the resolutions for consideration by

shareholders at a special meeting of shareholders to be held on 4 December 2018.

In order to rectify this situation, and ensure compliance with the NZX Listing Rules, Mr Brankin has

resigned today as a director of the company and has been reappointed immediately by the

independent directors. Mr Brankin has consented to his appointment as a director of the company.

Mr Brankin will be required to have his re-election placed before shareholders at the 2019 annual

meeting of shareholders.

The directors consider that Mr Brankin is not an independent director.


Stephen Underwood

Chairman

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.